Amphenol CEO Richard Norwitt Exercises Options, Sells Shares

What Happened
Richard (Adam) Norwitt, President & CEO and a director of Amphenol (APH), exercised stock options and sold the resulting shares on July 31, 2026. He exercised 500,000 options at $22.37 (cost $11,186,250) and 186,104 options at $22.37 (cost $4,163,612), and then sold those 500,000 and 186,104 shares in open-market transactions. The sales generated gross proceeds of about $80.79M (500,000 @ $161.57) and $30.20M (186,104 @ $162.27), for total sale proceeds of approximately $110.99M. The filing shows corresponding derivative entries at $0.00 reflecting the conversion/termination of the options.

Key Details

• Transaction date: July 31, 2026 (filed Aug 3, 2026 — within the 2-business-day Form 4 deadline).
• Exercise (code M): 500,000 shares @ $22.37 (acquired) = $11,186,250; 186,104 @ $22.37 (acquired) = $4,163,612.
• Open-market sales (S): 500,000 shares @ weighted avg $161.57 = $80,787,400 (F1/F3; trades ranged $160.50–$166.3050); 186,104 shares @ weighted avg $162.27 = $30,199,319 (F1/F2; trades ranged $160.50–$162.37).
• Derivative disposition lines (500,000 and 186,104 @ $0.00) record the option instruments converted/terminated upon exercise.
• Footnotes: F1 notes weighted-average sale price available on request; F2/F3 show per-trade ranges; F4 notes some shares are owned through the reporting person’s IRA.
• Shares owned after the transactions: not specified in the information provided in this summary filing.

Context

• This is a textbook cashless-style exercise and immediate sale: options were exercised at $22.37 and the shares were promptly sold at market prices well above the exercise price. Such transactions are common for executives exercising compensation awards and do not, by themselves, indicate a view on the company’s near-term prospects.
• The filing appears timely (transaction 7/31/2026; Form 4 filed 8/3/2026).